EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care diagnostics business, announces the appointment of Richard Evans to the Board as Finance Director, with immediate effect. Richard will replace Paul Foulger who has been fulfilling the role on a part-time basis and Paul will continue in the role of Company Secretary.
Richard joins EKF from Hitachi Data Systems GmbH where he has worked since 2002, firstly as Finance Director, where he had overall responsibility for the finance function in Germany, then General Manager and finally as Global Account Director.
Before joining Hitachi Richard held senior positions with various corporations across Europe. Richard was previously Vice-President Controller Europe for Fisher Scientific Worldwide, Finance Director of TRW Seat Belt Systems Europe, and held various roles with the Maxtor Corporation, United Technologies Carrier and Abbott Diagnostic Products GmbH in Germany.
Richard qualified as a Chartered Management Accountant in 1983 and holds a degree from Edinburgh University and a Masters in Business Administration from INSEAD.
"We are very pleased to announce the appointment of Richard to the Board. Since joining EKF in February this year Richard has been instrumental in helping us move EKF from an owner-managed structure and culture to one that meets the demands of the higher-growth and higher-governance led business we are trying to create. Richard's ability to speak fluent German has been enormously helpful in this transitional process and we look forward to his contribution to the Board."
Richard Anthony Evans, aged 54, holds 96,700shares in the Company and there is no further information to be disclosed under schedule 2(g) and Rule 17 of the AIM Rules in respect of Mr Evans' appointment today as a Director of the Company. Richard is the brother of David Evans, Executive Chairman.
EKF Diagnostics Holdings plc was formed in July 2010 following the acquisition of EKF-diagnostic GmbH for €14.32m and refocused its strategy to one of building a substantial point of care diagnostics business. As part of this strategy, the Group has integrated three further acquisitions, Quotient Diagnostics Limited (acquired in October 2010 for a maximum of £5.41m), Argutus Medical Limited (acquired in December 2010 for £2.18m) and Stanbio Laboratory L.P. (acquired in June 2011 for a maximum of US$25.5m).
The Company, with its head office in Cardiff and operations in London, Germany, Poland, Russia, Ireland and the US, is a leading diagnostics business, focused on the development, production and distribution of chemical reagents and analysers for the testing of Glucose, Lactate, Haemoglobin, Haematocrit and HbA1c.
In May 2011 EKF entered into a distribution agreement with Alere Inc ("Alere"), a global diagnostics company, under which Alere was appointed the exclusive distributor of EKF's CLIA waived Hemo_Control device and cuvettes in the US, Canada and United Kingdom.
Datafeed and UK data supplied by NETbuilder and Interactive Data.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.